Cancer metabolomic markers in urine: evidence, techniques and recommendations [0.03%]
尿液癌症代谢标志物：证据、技术与建议
Sarah S Dinges,Annika Hohm,Lindsey A Vandergrift et al.
Sarah S Dinges et al.
Urinary tests have been used as noninvasive, cost-effective tools for screening, diagnosis and monitoring of diseases since ancient times. As we progress through the 21st century, modern analytical platforms have enabled effective measureme...
A new era: artificial intelligence and machine learning in prostate cancer [0.03%]
前列腺癌时代来临：人工智能与机器学习
S Larry Goldenberg,Guy Nir,Septimiu E Salcudean
S Larry Goldenberg
Artificial intelligence (AI) - the ability of a machine to perform cognitive tasks to achieve a particular goal based on provided data - is revolutionizing and reshaping our health-care systems. The current availability of ever-increasing c...
Andrea Garretto,Taylor Miller-Ensminger,Alan J Wolfe et al.
Andrea Garretto et al.
The discovery of bacteria in the female urinary bladder has fundamentally changed current dogma regarding the urinary tract and related urinary disorders. Previous research characterized many of the bacterial components of the female urinar...
Publisher Correction: The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol [0.03%]
订正：2016年UMBRELLA SIOP-RTSG肾母细胞瘤病理和分子生物学方案
Gordan M Vujanić,Manfred Gessler,Ariadne H A G Ooms et al.
Gordan M Vujanić et al.
In the version of this article initially published online it was not open access, this has now been corrected.
Published Erratum
Nature reviews. Urology. 2019 Sep;16(9):563. DOI:10.1038/s41585-019-0191-5 2019
Clemens Thoma
Clemens Thoma
Louise Stone
Louise Stone
Louise Stone
Louise Stone
Louise Stone
Louise Stone
Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA - update 2018 [0.03%]
蓝光柔性膀胱镜（使利华）在非肌层浸润性膀胱癌中的临床应用：美国最佳使用共识声明更新版(2018)
Yair Lotan,Trinity J Bivalacqua,Tracy Downs et al.
Yair Lotan et al.
Blue light cystoscopy (BLC) with hexaminolevulinate (HAL) during transurethral resection of bladder cancer improves detection of non-muscle-invasive bladder cancer (NMIBC) and reduces recurrence rates. Flexible BLC was approved by the FDA i...